Novanta (NOVT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
3 Jun, 2026Opening remarks and agenda
Chair and CEO welcomed attendees, introduced board members, executive team, and independent auditor.
Meeting called to order, agenda and rules of conduct made available on the virtual platform.
Voting procedures and eligibility explained, with scrutineer introduced to oversee voting.
Financial performance review
Audited consolidated financial statements for the year ended December 31, 2025, and auditor's report were presented and made available to shareholders.
Board and executive committee updates
Board nominees for the next term were introduced, with terms expiring at the 2027 annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Novanta
- Acquisition doubles recurring revenue, delivers $80M+ synergies, and closes Q3 2026.NOVT
M&A announcement10 Jun 2026 - Fourfold revenue growth driven by innovation in medical and automation markets.NOVT
Investor presentation8 Jun 2026 - Medical and robotics focus drives recurring revenue and double-digit growth through innovation and M&A.NOVT
46th Annual William Blair Growth Stock Conference6 Jun 2026 - Q1 2026 revenue up 10.4%, bookings up 37%, and cash flow surged, with strong 2026 outlook.NOVT
Q1 202612 May 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.NOVT
Proxy filing24 Apr 2026 - Record revenue, strong bookings, and 2026 guidance project further growth and margin expansion.NOVT
Q4 202510 Apr 2026 - Q2 revenue up 2.8% to $236M, with medical growth offsetting weak industrial demand.NOVT
Q2 20242 Feb 2026 - Q3 2024 revenue up 10.3% to $244.4M, with acquisitions driving growth and flat organic sales.NOVT
Q3 202416 Jan 2026 - 2024 saw record cash flow, margin gains, and new products; 2025 targets 5% growth amid volatility.NOVT
Q4 202411 Dec 2025